Little House Capital LLC acquired a new stake in CME Group Inc. (NASDAQ:CME - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 6,459 shares of the financial services provider's stock, valued at approximately $1,714,000.
Other large investors also recently bought and sold shares of the company. New Age Alpha Advisors LLC grew its position in shares of CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after buying an additional 43 shares in the last quarter. Golden State Wealth Management LLC grew its position in shares of CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after buying an additional 98 shares in the last quarter. Alpine Bank Wealth Management acquired a new stake in shares of CME Group during the first quarter worth approximately $32,000. Knuff & Co LLC acquired a new stake in shares of CME Group during the fourth quarter worth approximately $33,000. Finally, Banque Transatlantique SA acquired a new stake in shares of CME Group during the fourth quarter worth approximately $35,000. Institutional investors and hedge funds own 87.75% of the company's stock.
Insiders Place Their Bets
In other news, Director William R. Shepard purchased 256 shares of CME Group stock in a transaction dated Wednesday, June 25th. The stock was acquired at an average cost of $270.53 per share, for a total transaction of $69,255.68. Following the acquisition, the director now directly owns 258,196 shares in the company, valued at $69,849,763.88. This represents a 0.10% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Daniel G. Kaye sold 500 shares of the company's stock in a transaction on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total value of $141,210.00. Following the completion of the sale, the director now owns 3,668 shares in the company, valued at $1,035,916.56. This trade represents a 12.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 13,400 shares of company stock worth $3,680,610. 0.30% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
A number of research firms have recently weighed in on CME. Bank of America raised their price target on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research report on Wednesday, April 2nd. Oppenheimer raised their price objective on CME Group from $282.00 to $300.00 and gave the stock an "outperform" rating in a research note on Wednesday, June 4th. Barclays raised their price objective on CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a research note on Wednesday, April 23rd. Piper Sandler raised their price objective on CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 8th. Finally, Erste Group Bank cut CME Group from a "strong-buy" rating to a "hold" rating in a research note on Saturday, May 24th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and an average price target of $258.20.
Check Out Our Latest Stock Report on CME Group
CME Group Trading Up 0.7%
Shares of CME opened at $274.76 on Friday. The business's 50-day moving average price is $275.21 and its 200 day moving average price is $256.53. The stock has a market capitalization of $99.01 billion, a P/E ratio of 27.64, a P/E/G ratio of 3.70 and a beta of 0.45. CME Group Inc. has a 1-year low of $193.17 and a 1-year high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.
CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The firm had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same period last year, the company posted $2.50 EPS. The business's quarterly revenue was up 10.4% compared to the same quarter last year. Analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were given a dividend of $1.25 per share. The ex-dividend date was Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.82%. CME Group's payout ratio is presently 50.30%.
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.